Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Res
- PDF / 194,474 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 95 Downloads / 180 Views
(2020) 21:961
CORRECTION
Open Access
Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute noninvasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease On behalf of the Rescue2-monitor group1,2 Correction to: Trials 21, 877 (2020) https://doi.org/10.1186/s13063-020-04672-w After publication of the original article [1], it came to the authors’ attention that one sponsor declaration was missing in the funding section. The funding section of the original article has been updated as follows in order to include L3medical as additional sponsor. Funding: Monetary support for sponsoring the study will be provided by La Fondation du Souffle (ex. BREAS), Sociedad espanola de neumologia y de The original article can be found online at https://doi.org/10.1186/s13063020-04672-w. Correspondence: [email protected] 1 Gonzalez-Bermejo, J. Sorbonne Université, INSERM, UMRS1158, Neurophysiologie Respiratoire Expérimentale et Clinique, 75005 Paris, France 2 AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation, (Département R3S), 75013 Paris, France
cirurgia toracica (SEPAR), the Société de pneumologie de langue française (SPLF), L3medical, and Air Liquide Healthcare. La Fondation du Souffle, as sponsor, is involved in the data collection and has ownership of the data. However, it has no involvement in design of the study, analysis, and interpretation of the data and in writing the protocol/manuscript. The SEPAR and SPLF were involved in the design of the study and will be involved in data analysis and interpretation as well as the writing of protocol/manuscripts. Air Liquide Healthcare is not involved in any of the following aspects: study design; collection, management, analysis, and interpretation of data; writing of the protocol or manuscript.
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.
Data Loading...
